Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients

OBJECTIVE: Metabolic associated fatty liver disease (MAFLD) affects nearly a quarter of the world’s population. Our study aimed to characterize the gut microbiome and overall changes in the fecal and serum metabolomes in MAFLD patients. METHODS: Thirty-two patients diagnosed with MAFLD and 30 health...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lidan, Dai, Yuzhao, He, He, Liu, Zhi, Liao, Shenling, Zhang, Yu, Liao, Ga, An, Zhenmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441872/
https://www.ncbi.nlm.nih.gov/pubmed/36071958
http://dx.doi.org/10.3389/fmicb.2022.969757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441872/
https://www.ncbi.nlm.nih.gov/pubmed/36071958
http://dx.doi.org/10.3389/fmicb.2022.969757

Ejemplares similares